Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1739)
  2. Meeting Abstract (876)
  3. Book Section (108)
  4. Review (66)
  5. Editorial (57)
  6. Research Letter (42)
  7. Conference Paper (26)
  8. Guidelines (26)
  9. Correspondence (21)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1656)
  2. Survivorship Research (1180)
  3. Solid Tumor Oncology Division (1026)
  4. Department of Pathology and Laboratory Medicine (939)
  5. Surgery (934)
  6. Melanoma and Immunotherapeutics Service (777)

More Groups

People
  1. Klaus Busam (685)
  2. Daniel Coit (540)
  3. Allan Halpern (396)
  4. Michael Postow (356)
  5. Alexander Shoushtari (244)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (38)
  2. 2024 (136)
  3. 2023 (161)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (287)
  2. Annals of Surgical Oncology (220)
  3. Journal of the American Academy of Dermatology (121)
  4. Journal of Investigative Dermatology (80)
  5. Cancer Research (75)
  6. Clinical Cancer Research (67)

More Publications

Publishers
  1. Springer (347)
  2. American Society of Clinical Oncology (301)
  3. Elsevier Inc. (249)
  4. American Association for Cancer Research (234)
  5. Lippincott Williams & Wilkins (231)
  6. Wiley Blackwell (170)

More Publishers

Results (2988)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An open label phase IIa study evaluating the preliminary efficacy of intratumoural tigilanol tiglate (TT) in advanced and/or metastatic soft tissue sarcoma (STS)
    Meeting Abstract

    Bartlett, E. K.; Li, D.; Shemla, S.; Ariyan, C. E.; Dickinson, S.; Crago, A.; Li, G.; Agaram, N.; D'Angelo, S. P.; Maki, R. G.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • First-line immunotherapy versus BRAF and MEK inhibitors for patients with BRAF V600E mutant metastatic non-small cell lung cancer
    Meeting Abstract

    Di Federico, A.; Chen, M. F.; Pagliaro, A.; Ogliari, F. R.; Stockhammer, P.; Aldea, M.; Grant, M.; De Giglio, A.; Alessi, J. V.; Pecci, F.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitor rechallenge after treatment with tumor-infiltrating lymphocytes in unresectable melanoma
    Meeting Abstract

    Betof Warner, A.; Smithy, J. W.; Los, C.; Kalvin, H.; Hasson, N.; Amaria, R. N.; Andrade Czapla, J. A.; Schollenberger, M.; furness, A.; Hassel, J. C.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • NivoLag-when: International real-world study of combination immunotherapy sequences in melanoma
    Meeting Abstract

    Guardamagna, M.; Marqueste, C. G.; Malissen, N.; Roy, S.; da Silva, I. P.; Long, G. V.; Smithy, J. W.; Postow, M. A.; Dimitriou, F.; Dummer, R.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy of LNS8801 in melanoma patients with prior immune-related adverse events from immune-checkpoint inhibitors
    Meeting Abstract

    Cohen, J. V.; Garyantes, T. K.; Muller, C.; Natale, C. A.; Orloff, M.; Patel, S.; Rodon, J.; Shoushtari, A. N.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Longitudinal biomarker analysis and outcomes for patients (pts) treated with neoadjuvant nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma
    Meeting Abstract

    Burton, E.; Wani, K.; Milton, D.; Lazcano, R.; Tetzlaff, M.; Ross, M. I.; Postow, M. A.; Glitza, I. C.; Wong, M. K. K.; Patel, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • HERTHENA-PanTumor01: A global phase II trial of HER3-DXd in metastatic solid tumors
    Meeting Abstract

    Powles, T. B.; Bhatia, A. K.; Burtness, B.; Kogawa, T.; Nishina, T.; Nakayama, I.; Fountzilas, C.; Castillo, D. R.; McKean, M.; Meric-Bernstam, F.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Association of a blood T cell fitness gene signature with clinical benefit from ImmTAC bispecific T cell engagers
    Meeting Abstract

    Sacco, J. J.; Carvajal, R. D.; Hamid, O.; Kirk, P. B.; Collins, L.; Butler, M. O.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A. P.; Hernandez-Aya, L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Dual-vector-transduction with single-step magnetic selection (Zip-sort) increases transgenic payloads to enhance CAR T cell activity
    Meeting Abstract

    James, S. E.; Chen, S.; Ng, B.; Fischman, J.; Jahn, L.; Boardman, A. P.; Rajagopalan, A.; Elias, H. K.; Massa, A. R.; Manuele, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Hemi-skin electron therapy: The relationship between shield height and treatment margin
    Meeting Abstract

    Donahue, W. P.; Ocana, J.; Niyazov, G.; Barker, C.; Hellman, S.; Lim, S. B.
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save